Technological advances empower the modification of NK cells and renewed potential for therapeutic uses in cancer and autoimmunity.

such as antigen presentation by dendritic cells (DCs), natural killer (NK)-cell cytotoxicity and the activation of neutrophils. However, activated NK cells can also kill MSCs. MSCs inhibit T-cell ...

Chimeric antigen receptors (CARs) are modular synthetic molecules that redirect immune cell cytotoxicity toward tumor cells expressing ... two types of CAR cell therapy: CAR-T and CAR-natural killer ...

Three-dimensional migration assays confirmed that SPON2 promoted the directional migration of NK cells toward tumor cells.

The following is a summary of “FcγR3A polymorphism influences natural killer cell activation and response to anti-PD-L1 ...

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...

Following the discovery of inhibitory KIR and the understanding that they play a role in preventing NK cell killing of self MHC I-expressing tumor cells, investigators began to research the ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a commercial-stage company dedicated to developing and delivering precision diagnostic consumer products, announced today that it has ...

Artiva’s lead program, AlloNK ®, is an allogeneic, off-the-shelf, non-genetically modified, cryopreserved NK cell therapy ...